reference/22949477

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/22949477

Outgoing Links

Predicate	Object
contentType	Comparative Study\|Journal Article
endingPage	771
issn	1365-2141 0007-1048
issueIdentifier	5
pageRange	756-771
publicationName	British Journal of Haematology
startingPage	756
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_f62ca797c128f7085c86d9be4426d208 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_53bc736c5760dcd3fa45240502f6bb38 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_eb4f340a1767b2ff28113b9d3c67834b http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_73788372f6235cb300691a7b37af8b4d http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_c0cfd9594cf2613a5493eb392768553c http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_7aaeadf8c285f61e4bd43f0e37045be1 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_a3f94740843da101f918196ff19d4fef
bibliographicCitation	Cholujova D, Bujnakova Z, Dutkova E, Hideshima T, Groen RW, Mitsiades CS, Richardson PG, Dorfman DM, Balaz P, Anderson KC, Jakubikova J. Realgar nanoparticles versus ATO arsenic compounds induce in vitro and in vivo activity against multiple myeloma. Br J Haematol. 2017 Oct 19;179(5):756–71. doi: 10.1111/bjh.14974.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9498feecde0f741a54de358fd180845c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f8c765f513a3f0f7139e18fa34fcecec http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-2593-569X http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b097b76897adc29efcde62f0ff420f6f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_57df8ccd327ab392aced50ec01d6a668 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8a07236021ad87a5a5485764a5d45a4d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9fe722693c4f1dd1fa89c09dc1805cba http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_edea87e2623a43e21d5be930113de2ed http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4da8c340e06cfc010b389944cac12453 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-7426-8865 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8418a0a26f1cbf8f99daa0b6651fe1fc
date	2017-10-19^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/29048129 https://pubmed.ncbi.nlm.nih.gov/PMC5705577 https://doi.org/10.1111/bjh.14974
isPartOf	https://portal.issn.org/resource/ISSN/1365-2141 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1822 https://portal.issn.org/resource/ISSN/0007-1048
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Realgar nanoparticles versus ATO arsenic compounds induce in vitro and in vivo activity against multiple myeloma
discusses	http://id.nlm.nih.gov/mesh/M000748982 http://id.nlm.nih.gov/mesh/M0049263 http://id.nlm.nih.gov/mesh/M0001724 http://id.nlm.nih.gov/mesh/M0491920 http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0015648 http://id.nlm.nih.gov/mesh/M0020772 http://id.nlm.nih.gov/mesh/M0162684
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D009101Q000188 http://id.nlm.nih.gov/mesh/D010087Q000008 http://id.nlm.nih.gov/mesh/D013440Q000008 http://id.nlm.nih.gov/mesh/D000970Q000008 http://id.nlm.nih.gov/mesh/D001152Q000008
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D016923Q000187 http://id.nlm.nih.gov/mesh/D023041 http://id.nlm.nih.gov/mesh/D045744 http://id.nlm.nih.gov/mesh/D002453Q000187 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D000971Q000627 http://id.nlm.nih.gov/mesh/D000971Q000494 http://id.nlm.nih.gov/mesh/D014407 http://id.nlm.nih.gov/mesh/D004305 http://id.nlm.nih.gov/mesh/D010087Q000627 http://id.nlm.nih.gov/mesh/D001152Q000494 http://id.nlm.nih.gov/mesh/D053758 http://id.nlm.nih.gov/mesh/D010087Q000494 http://id.nlm.nih.gov/mesh/D016513 http://id.nlm.nih.gov/mesh/D009101Q000473 http://id.nlm.nih.gov/mesh/D000091402 http://id.nlm.nih.gov/mesh/D058990Q000379 http://id.nlm.nih.gov/mesh/D014411Q000187 http://id.nlm.nih.gov/mesh/D000970Q000627 http://id.nlm.nih.gov/mesh/D000970Q000494 http://id.nlm.nih.gov/mesh/D000077237 http://id.nlm.nih.gov/mesh/D016503Q000379 http://id.nlm.nih.gov/mesh/D001152Q000627 http://id.nlm.nih.gov/mesh/D017209Q000187 http://id.nlm.nih.gov/mesh/D013440Q000494 http://id.nlm.nih.gov/mesh/D006801
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8530 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_bf99a94c673fe4e93461af6be7e99f9e http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID460612 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5359596 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_24fcc8ae2c4a3fc4fe2b5ecda59a20f4 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_75be19437755fc2af3f5756d6bb1d737 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID216326 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_52a517e173e6fa70285ded085be0d86f http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_98035231fcaee69b50d4e6e928e41169 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14888 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_07edfd5399a4297179b0eb6e7ec0142a http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_392a4c4eacfdd8813543206f715ca6ee http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f1b2452da84551fc91db93425b6a20d9 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f7f9050e59c89962f38190b76545ac23 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b99b20ddd6f60c61b160c3993b86b4a6 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_582d5f2f504253c89e3a8210d6134600

Showing number of triples: 1 to 96 of 96.